The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and clinical studies without systematic review methodology.
PubMed 24564669 · doi:10.33549/physiolres.932715
What was done
This narrative review synthesized mechanistic insights from dietary obese mouse experiments along with human observational and randomized trial literature evaluating the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity, glucose homeostasis, and cardiovascular outcomes across healthy, prediabetic, and type 2 diabetic populations.
What was found
The abstract reports qualitative findings without numerical metrics. Animal experiments consistently showed beneficial effects of omega-3 on insulin sensitivity and glucose metabolism during obesity and insulin resistance. In humans, positive results occurred in healthy cohorts and some prediabetic intervention trials. However, the majority of clinical trials in patients with type 2 diabetes showed no or marginal effects on metabolic control, despite effective reductions in hypertriglyceridemia, and recent trials generally did not support efficacy in secondary cardiovascular prevention.
Why it matters
It highlights a clear translational gap: robust metabolic improvements seen with omega-3 fatty acids in animal models do not consistently translate to glycemic control benefits in humans with established type 2 diabetes.
Limits
The abstract reports no numerical data, effect sizes, or study counts. As a narrative review, it lacks systematic search criteria, and evidence for glycemic efficacy in human clinical populations remains weak or absent.
Cited by
- supports In rodent studies, omega-3 supplementation has positive effects on insulin sensitivity and glucose regulation, but evidence in humans is mixed and less convincing.